In the bustling landscape of New York’s agency world, staying ahead of the curve is not just a goal—it’s a necessity. In an era where consumer preferences evolve rapidly and industries undergo constant disruption, the traditional methods of market research, particularly in healthcare, are undergoing a profound transformation. Gone are the days of relying solely on ad hoc focus groups for insights; instead, we’re witnessing a seismic shift towards a continuous supply of curated data, driven by the unparalleled capabilities of Artificial Intelligence (AI).
The traditional model of ad hoc focus groups, while valuable in its time, often falls short in today’s fast-paced, data-driven environment. These approaches are typically resource-intensive, time-consuming, and limited in scope. For strategists in New York agencies, this poses a significant challenge, especially when catering to clients in industries such as healthcare, where understanding patient attitudes and behaviors is paramount.
Enter AI-driven insights—a game-changer for agencies navigating the complex landscape of market research.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. The Talking Medicines mission is to be the World’s Gold Standard for Patient Intelligence by Medicine.
